NCT00487578View on ClinicalTrials.gov

Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction

PHASE4TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Post Traumatic Headache
Interventions
DRUG

naratriptan HCl

naratriptan 2.5mg tablet bid x 30 days OR matching placebo

Trial Locations (3)

28203

Carolinas Rehabilitation, Carolinas HealthCare System, Charlotte

65807

Clinvest, Springfield

75231

Anodyne Headache and Pain Care, Dallas

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Clinvest

OTHER

lead

Cady, Roger, M.D.

INDIV